Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran

Frontiers in Microbiology

Volumn 6, Issue OCT, 2015, Pages

  Farshadzadeh, Zahra ^a   Hashemi, Farhad B ^a   Rahimi, Sara ^b   Pourakbari, Babak ^a   Esmaeili, Davoud ^c   Haghighi, Mohammad A ^b   Majidpour, Ali ^d   Shojaa, Saeed ^e   Rahmani, Maryam ^a   Gharesi, Samira ^a   Aziemzadeh, Masoud ^b   Bahador, Abbas ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e HORMOZGAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antimicrobial resistance; Integron; International clone; MLST; MLVA

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BURN PATIENT; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; GENE CASSETTE; GENETIC PROCEDURES; GENETIC VARIABILITY; HUMAN; INTEGRON; IRAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; MULTIPLE LOCUS VARIABLE NUMBER OF TANDEM REPEAT ANALYSIS; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PHENOTYPE; PREVALENCE; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 84946819969     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.01146     Document Type: Article

References (55)

1. Alaghehbandan, R., Azimi, L., and Rastegar Lari, A. (2012). Nosocomial infections among burn patients in Teheran, Iran: a decade later. Ann. Burns Fire Disasters 25, 3-7.
2. Almeida, L. A., and Araujo, R. (2013). Highlights on molecular identification of closely related species. Infect. Genet. Evol. 13, 67-75. doi: 10.1016/j.meegid
3. Altunsoy, A., Aypak, C., Azap, A., Ergönül, Ö, and Balik, I. (2011). The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey. Int. J. Med. Sci. 8, 339-344.
4. Azimi, L., Talebi, M., Pourshafie, M. R., Owlia, P., and Rastegar Lari, A. (2015). Characterization of carbapenemases in extensively drug resistance Acinetobacter baumannii in a burn care center in Iran. Int. J. Mol. Cell Med. 4, 46-53.
5. Badave, G. K., and Kulkarni, D. (2015). Biofilm producing multidrug resistant Acinetobacter baumannii: an emerging challenge. J. Clin. Diagn. Res. 9, 8-10. doi: 10.7860/JCDR/2015/11014.5398
6. Bahador, A., Raoofian, R., Taheri, M., Pourakbari, B., Hashemizadeh, Z., and Hashemi, F. B. (2014). Multidrug resistance among Acinetobacter baumannii isolates from Iran: changes in antimicrobial susceptibility patterns and genotypic profile. Microb. Drug Resist. 20, 632-640. doi: 10.1089/mdr.2013.0146
7. Bahador, A., Taheri, M., Pourakbari, B., Hashemizadeh, Z., Rostami, H., Mansoori, N., et al. (2013). Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants. Microb. Drug Resist. 19, 397-406. doi: 10.1089/mdr.2012.0233
8. Bartual, S. G., Seifert, H., Hippler, C., Luzon, M. A., Wisplinghoff, H., and Rodríguez-Valera, F. (2005). Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43, 4382-4390. doi: 10.1128/JCM.43.9.4382-4390.2005
9. Bonnin, R. A., Nordmann, P., Potron, A., Lecuyer, H., Zahar, J. R., and Poirel, L. (2011a). Carbapenem-hydrolyzing ges-type extended-spectrum β-Lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 55, 349-354. doi: 10.1128/AAC.00773-10
10. Bonnin, R. A., Potron, A., Poirel, L., Lecuyer, H., Neri, R., and Nordmann, P. (2011b). PER-7, an extended-spectrum β-lactamase with increased activity toward broad-Spectrum cephalosporins in Acinetobacter baumannii. Antimicrob. Agents Chemother. 55, 2424-2427. doi: 10.1128/AAC.01795-10
11. Bou, G., and Martinez-Beltran, J. (2000). Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 44, 428-432. doi: 10.1128/AAC.44.2.428-432.2000
12. Cai, Y., Chai, D., Wang, R., Liang, B., and Bai, N. (2012). Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J. Antimicrob. Chemother. 67, 1607-1615. doi: 10.1093/jac/dks084
13. Castanheira, M., Costello, S. E., Woosley, L. N., Deshpande, L. M., Davies, T. A., and Jones, R. N. (2014). Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel β-lactamases, GES-22 and VIM-35. Antimicrob. Agents Chemother. 58, 7358-7366. doi: 10.1128/AAC.03930-14
14. Chen, Y., Zhou, Z., Jiang, Y., and Yu, Y. (2011). Emergence of NDM-1-producing Acinetobacter baumannii in China. J. Antimicrob. Chemother. 66, 1255-1259. doi: 10.1093/jac/dkr082
15. Climaco, E. C., Oliveira, M. L., Pitondo-Silva, A., Oliveira, M. G., Medeiros, M., Lincopan, N., et al. (2013). Clonal complexes 104, 109 and 113 playing a major role in the dissemination of OXA-carbapenemase-producing Acinetobacter baumannii in Southeast Brazil. Infect. Genet. Evol. 19, 127-133. doi: 10.1016/j.meegid.2013.06.024
16. Clinical and Laboratory Standards Institute [CLSI] (2014). Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty fourth Informational Supplement M100-S24CLSI. Wayne, PA: CLSI.
17. Diancourt, L., Passet, V., Nemec, A., Dijkshoorn, L., and Brisse, S. (2010). The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS ONE 5:e10034. doi: 10.1371/journal.pone.0010034
18. Dillon, B., Thomas, L., Mohmand, G., Zelynski, A., and Iredell, J. (2005). Multiplex PCR for screening of integrons in bacterial lysates. J. Microbiol. Methods 62, 221-232. doi: 10.1016/j.mimet.2005.02.007
19. Ellington, M. J., Kistler, J., Livermore, D. M., and Woodford, N. (2007). Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J. Antimicrob. Chemother. 59, 321-322. doi: 10.1093/jac/dkl481
20. European Committee on Antimicrobial Susceptibility Testing. (2014). Version 4. 0.
21. Fishbain, J., and Peleg, A. Y. (2010). Treatment of Acinetobacter infections. Clin. Infect. Dis. 51, 79-84. doi: 10.1086/653120
22. Giannouli, M., Cuccurullo, S., Crivaro, V., Di Popolo, A., Bernardo, M., Tomasone, F., et al. (2010). Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone. J. Clin. Microbiol. 48, 1223-1230. doi: 10.1128/JCM.02263-09
23. Girerd-Genessay, I., Bénet, T., and Vanhems, P. (2015). Multidrug-resistant bacterial outbreaks in burn units: a synthesis of the literature according to the orion statement. J. Burn Care Res. [Epub ahead of print]
24. Heritier, C., Poirel, L., and Nordmann, P. (2006). Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin. Microbiol. Infect. 12, 123-130. doi: 10.1111/j.1469-0691.2005.01320.x
25. Higgins, P. G., Lehmann, M., and Seifert, H. (2010a). Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 35:305. doi: 10.1016/j.ijantimicag.2009.10.014
26. Higgins, P. G., Lehmann, M., Wisplinghoff, H., and Seifert, H. (2010b). gyrB Multiplex PCR To differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J. Clin. Microbiol. 48, 4592-4594. doi: 10.1128/JCM.01765-10
27. Hojabri, Z., Pajand, O., Bonura, C., Aleo, A., Giammanco, A., and Mammina, C. (2014). Molecular epidemiology of Acinetobacter baumannii in Iran: endemic and epidemic spread of multiresistant isolates. J. Antimicrob. Chemother. 69, 2383-2387. doi: 10.1093/jac/dku045
28. Japoni-Nejad, A., Farshad, S., van Belkum, A., and Ghaznavi-Rad, E. (2013). Novel cassette array in a class 1 integron in clinical isolates of Acinetobacter baumannii from central Iran. Int. J. Med. Microbiol. 303, 645-650. doi: 10.1016/j.ijmm.2013.09.005
29. Jeannot, K., Diancourt, L., Vaux, S., Thouverez, M., Ribeiro, A., Coignard, B., et al. (2014). Molecular epidemiology of carbapenem non-susceptible Acinetobacter baumannii in France. PLoS ONE 9:e115452. doi: 10.1371/journal.pone.0115452
30. Karah, N., Sundsfjord, A., Towner, K., and Samuelsen, Ø (2012). Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist. Updat. 15, 237-247. doi: 10.1016/j.drup.2012.06.001
31. Liu, C. C., Tang, C. Y., Chang, K. C., Kuo, H. Y., and Liou, M. L. (2014a). A comparative study of class 1 integrons in Acinetobacter baumannii. Gene 544, 75-82. doi: 10.1016/j.gene.2014.04.047
32. Liu, C. P., Shih, S. C., Wang, N. Y., Wu, A. Y., Sun, F. J., Chow, S. F., et al. (2014b). Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia. J. Microbiol. Immunol. Infect. doi: 10.1016/j.jmii.2014.10.006 [Epub ahead of print].
33. Longo, F., Vuotto, C., and Donelli, G. (2014). Biofilm formation in Acinetobacter baumannii. N. Microbiol. 37, 119-127.
34. Magiorakos, A. P., Srinivasan, A., Carey, R., Carmeli, Y., Falagas, M. E., Giske, C. G., et al. (2012). Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18, 268-281. doi: 10.1111/j.1469-0691
35. Mahdian, S., Sadeghifard, N., Pakzad, I., Ghanbari, F., Soroush, S., Azimi, L., et al. (2015). Acinetobacter baumannii clonal lineages I and II harboring different carbapenem-hydrolyzing-β-lactamase genes are widespread among hospitalized burn patients in Tehran. J. Infect. Public Health doi: 10.1016/j.jiph.2015.04.030 [Epub ahead of print].
36. Moradi, J., Hashemi, F. B., and Bahador, A. (2015). Antibiotic resistance of Acinetobacter baumannii in Iran: a systemic review of the published literature. Osong Public Health Res. Perspect. 6, 79-86. doi: 10.1016/j.phrp.2014.12.006
37. Nhu, N. T., Lan, N. P., Campbell, J. I., Parry, C. M., Thompson, C., Tuyen, H. T., et al. (2014). Emergence of carbapenem-resistant Acinetobacter baumannii as the major cause of ventilator-associated pneumonia in intensive care unit patients at an infectious disease hospital in southern Vietnam. J. Med. Microbiol. 63, 1386-1394. doi: 10.1099/jmm.0.076646-0
38. Öncül, O., Öksüz, S., Acar, A., Ülkür, E., Turhan, V., Uygur, F., et al. (2014). Nosocomial infection characteristics in a burn intensive care unit: analysis of an eleven-year active surveillance. Burns 40, 835-841. doi: 10.1016/j.burns
39. Penesyan, A., Gillings, M., and Paulsen, I. T. (2015). Antibiotic discovery: combatting bacterial resistance in cells, and in biofilm communities. Molecules 20, 5286-5298. doi: 10.3390/molecules20045286
40. Peymani, A., Farajnia, S., Nahaei, M. R., Sohrabi, N., Abbasi, L., Ansarin, K., et al. (2012a). Prevalence of class 1 integron among multidrug-resistant Acinetobacter baumannii in Tabriz, northwest of Iran. Pol. J. Microbiol. 61, 57-60.
41. Peymani, A., Higgins, P. G., Nahaei, M. R., Farajnia, S., and Seifert, H. (2012b). Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran. Int. J. Antimicrob. Agents 39, 526-528. doi: 10.1016/j.ijantimicag
42. Poirel, L., Menuteau, O., Agoli, N., Cattoen, C., and Nordmann, P. (2003). Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J. Clin. Microbiol. 41, 3542-3547. doi: 10.1128/JCM.41.8.3542-3547.2003
43. Potron, A., Munoz-Price, L. S., Nordmann, P., Cleary, T., and Poirel, L. (2011). Genetic features of CTX-M-15-producing Acinetobacter baumannii from Haiti. Antimicrob. Agents Chemother. 55, 5946-5948. doi: 10.1128/AAC.05124-11
44. Pourcel, C., Minandri, F., Hauck, Y., D'Arezzo, S., Imperi, F., Vergnaud, G., et al. (2011). Identification of variable-number tandem-repeat (VNTR) sequences in Acinetobacter baumannii and interlaboratory validation of an optimized multiple-locus VNTR analysis typing scheme. J. Clin. Microbiol. 49, 539-548. doi: 10.1128/JCM.02003-10
45. Rezaee, M. A., Pajand, O., Nahaei, M. R., Mahdian, R., Aghazadeh, M., Ghojazadeh, M., et al. (2013). Prevalence of Ambler class A β-lactamases and ampC expression in cephalosporin-resistant isolates of Acinetobacter baumannii. Diagn. Microbiol. Infect. Dis. 76, 330-334. doi: 10.1016/j.diagmicrobio
46. Robledo, I. E., Aquino, E. E., and Vazquez, G. J. (2011). Detection of the KPC gene in Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii during a PCR-based nosocomial surveillance study in Puerto Rico. Antimicrob. Agents Chemother. 55, 2968-2970. doi: 10.1128/AAC.01633-10
47. Ruan, Z., Chen, Y., Jiang, Y., Zhou, H., Zhou, Z., Fu, Y., et al. (2013). Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. Int. J. Antimicrob. Agents 42, 322-328. doi: 10.1016/j.ijantimicag
48. Salimizand, H., Menbari, S., Ramazanzadeh, R., Khonsha, M., and Vahedi, M. S. (2014). DNA fingerprinting and antimicrobial susceptibility pattern of clinical and environmental Acinetobacter baumannii isolates: a multicentre study. J. Chemother. [Epub ahead of print].
49. Sistanizad, M., Kouchek, M., Miri, M., Goharani, R., Solouki, M., Ayazkhoo, L., et al. (2013). Carbapenem restriction and its effect on bacterial resistance in an intensive care unit of a teaching hospital. Iran J. Pharm. Res. 12, 503-509.
50. Turton, J. F., Gabriel, S. N., Valderrey, C., Kaufmann, M. E., and Pitt, T. L. (2007). Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin. Microbiol. Infect. 13, 807-815. doi: 10.1111/j.1469-0691.2007.01759.x
51. Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M., et al. (2006). The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258, 72-77. doi: 10.1111/j.1574-6968.2006.00195.x
52. Woodford, N., Ellington, M. J., Coelho, J. M., Turton, J. F., Ward, M. E., Brown, S., et al. (2006). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27, 351-353. doi: 10.1016/j.ijantimicag.2006.01.004
53. Wu, K., Wang, F., Sun, J., Wang, Q., Chen, Q., Yu, S., et al. (2012). Class 1 integron gene cassettes in multidrug-resistant Gram-negative bacteria in southern China. Int. J. Antimicrob. Agents 40, 264-267. doi: 10.1016/j.ijantimicag
54. Zhang, D., Xia, J., Xu, Y., Gong, M., Zhou, Y., Xie, L., et al. (2014). Biological features of biofilm-forming ability of Acinetobacter baumannii strains derived from 121 elderly patients with hospital-acquired pneumonia. Clin. Exp. Med. [Epub ahead of print].
55. Zowawi, H. M., Sartor, A. L., Sidjabat, H. E., Balkhy, H. H., Walsh, T. R., Al Johani, S. M., et al. (2015). Molecular epidemiology of carbapenem resistant Acinetobacter baumannii in the gulf cooperation council states. Dominance of OXA-23-type producers. J. Clin. Microbiol. 53, 896-903. doi: 10.1128/JCM.02784-14